Pfizer stock trades at EUR 24.74, market cap USD 158.1 billion

Published on 10/08/2026 at 19:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pfizer stock stood at EUR 24.74 on October 8, 2026 after EUR 24.99, down 1.00 percent. Market value was USD 158.1 billion, with results due November 3, 2026.

Key points in brief

Pfizer stock was EUR 24.74 at Lang & Schwarz on October 8, 2026, down 1.00 percent versus EUR 24.99.
Pfizer's USD 158.1 billion market capitalization places it below Merck and Eli Lilly by market value.
The next earnings date is November 3, 2026, according to Investing.com.

Editorialfoto eines Trading-Floors mit Sektor-Charts, Symbolbild für den Aktienhandel von Pfizer Inc — Börsen-Editorialfoto vom Trading-Floor mit Pharma-Charts steht sinnbildlich für den Aktienhandel von Pfizer Inc., ISIN US7170811035, Illustration mit AI erstellt.

At Lang & Schwarz, Pfizer Inc. (ISIN US7170811035) was trading at EUR 24.74 on October 8, 2026 at 7:38 p.m. CEST, down 1.00 percent versus the prior close of EUR 24.99. The euro quote places the stock below the USD 27.74 price on the NYSE at 1:45 p.m. ET on the same date, a separate home-market indication.

Pfizer trades below its yearly high

The NYSE quote puts Pfizer's 52-week range at USD 23.62 to USD 29.21 as of October 8, 2026. The USD 27.74 home-market price stood USD 1.47, or 5.03 percent, below the 52-week high and USD 4.12, or 17.44 percent, above the low.

Lang & Schwarz showed a EUR 24.73 bid and a EUR 24.75 ask at 7:38 p.m. CEST. The primary-market quote was down 0.93 percent at the recorded time, while the euro quote was down 1.00 percent against its own prior close.

Valuation and the next reporting date

Pfizer's market capitalization was USD 158.1 billion on October 8, 2026, with a P/E ratio of 36.65 and a trailing dividend yield of 6.00 percent. The market value was lower than Merck's USD 347.3 billion and Eli Lilly's USD 1,082.9 billion, while Pfizer's P/E was below Merck's 112.53 and Eli Lilly's 38.59.

According to Investing.com, Pfizer's next earnings report is scheduled for November 3, 2026. That date gives the market a defined calendar point after the current price comparison, without changing the intraday status of the October 8 quote.

Comparison with peers

The peer figures below are as of October 8, 2026 at 1:45 p.m. ET.
Pfizer Inc. (NYSE, USD): minus 1.00 percent, P/E 36.65, market capitalization USD 158.1 billion
Merck & Co. (NYSE, USD): minus 1.51 percent, P/E 112.53, market capitalization USD 347.3 billion
Eli Lilly and Company (NYSE, USD): minus 3.27 percent, P/E 38.59, market capitalization USD 1,082.9 billion

Global Banking and Finance identifies Pfizer as PFE on the US listing, under ISIN US7170811035, and classifies the business in Health Care. The company develops and sells biopharmaceutical products, including medicines and vaccines, across international markets.

Pfizer price and market position

Pfizer's EUR 24.74 quote at Lang & Schwarz remained an after-hours indication at 7:38 p.m. CEST on October 8, 2026. The prior close was EUR 24.99, making the euro move a direct comparison with the previous Lang & Schwarz session.

The further course of trading is shown by the continuously updated real-time quote of Pfizer stock.